A Feasibility Study of the Cordis Neurovascular Self Expanding Stent System in Intracranial Arteries
Launched by CODMAN & SHURTLEFF · Jul 6, 2006
Trial Information
Current as of June 30, 2025
Completed
Keywords
ClinConnect Summary
Feasibility study to assess safety of treating patients with self expanding stent in intracranial arteries. Patients will be followed for 6 months with assessments related to technical feasibility and adverse events.
Gender
ALL
Eligibility criteria
- • Contact site for specific information
- Inclusion Criteria:
- • Subject meet specific criteria for treatment
- • Subject must be willing to return to site for 30 day and 6 month follow up evaluations
- Exclusion Criteria:
- • Stenting, angioplasty or endarterectomy of an extracranial (carotid or vertebral artery) or intracranial artery within 30 days prior to expected enrollment date
- • Previously implanted carotid stent associated with the symptomatic distribution within the past 12 weeks
About Codman & Shurtleff
Codman & Shurtleff, a subsidiary of Johnson & Johnson, is a leading medical device company specializing in innovative solutions for neurosurgery and other critical care areas. With a strong commitment to advancing patient care, Codman & Shurtleff develops cutting-edge technologies and products that enhance surgical outcomes and improve quality of life for patients. The company leverages extensive research and development capabilities to address complex clinical challenges, working closely with healthcare professionals to deliver safe and effective medical solutions. Through its dedication to clinical trials and evidence-based practice, Codman & Shurtleff plays a pivotal role in shaping the future of neurosurgical care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Belgrano, , Argentina
Patients applied
Trial Officials
Pedro Lylyk, MD
Principal Investigator
ENERI-CLINICA ADVENTISTA BELGRANO
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials